All surgeries for the first-in-man clinical study of the CARLO® system from AOT successful
On June 19, 2020, our Swiss portfolio company Advanced Osteotomy Tools (AOT) successfully completed the last surgery required for the first-in-man clinical study of its proprietary CARLO® system. Given the small delay due to COVID-19, we are now all the more pleased with the outcome. This takes the CARLO® (Cold Ablation Robot-guided Laser Osteotome) system one large step closer to achieving a CE mark. The surgical robotic platform, a world first, can be used to cut bones by means of cold laser ablation with extreme precision and care. This eliminates the need for conventional surgical tools. The system will be used in facial surgery, with neurosurgery and spinal surgery planned as further areas of indication for CARLO®. FDA submission is targeted for 2021.
For more information on this success story, click here.